Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Effects of Radioiodine on the Nasolacrimal System.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2022
Same author

Thyroid Abnormalities in Heart Failure.

Cardiology clinics·2022
Same author

Hypothyroid Symptoms in Levothyroxine-Treated Patients.

Innovations in pharmacy·2021
Same author

Thyroid Abnormalities in Heart Failure.

Heart failure clinics·2019
Same author

Assessment of the Adequacy of Thyroid Hormone Replacement Therapy in Hypothyroidism.

Frontiers in endocrinology·2019
Same author

Thyroid Hormones and Cardiovascular Function and Diseases.

Journal of the American College of Cardiology·2018

関連する実験動画

Updated: May 3, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.4K

甲状腺疾患と心臓の関係

Irwin Klein1, Sara Danzi

  • 1Department of Medicine and the Feinstein Institute for Medical Research, North Shore University Hospital, 350 Community Dr, Manhasset, NY 11030, USA. iklein@nshs.edu

Circulation
|October 10, 2007
PubMed
まとめ
この要約は機械生成です。

甲状腺疾患は,心臓血管の健康に重大な影響を及ぼし,心臓機能と血圧の変化を引き起こします. 甲状腺の正常なレベルを回復すると,これらの有害な効果はしばしば逆転する.

さらに関連する動画

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.0K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

750

関連する実験動画

Last Updated: May 3, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.4K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.0K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

750

科学分野:

  • 心臓病学 心臓病学
  • エンドクリノロジー エンドクリノロジー
  • 甲状腺学 甲状腺学について

背景:

  • 甲状腺機能障害は,甲状腺機能過剰症,甲状腺機能低下症を含む,心血管機能に深刻に影響を与えます.
  • 甲状腺ホルモンの作用の細胞メカニズムの理解は,変化した心電量,収縮性,血圧,血管抵抗,心律不整などの心血管の変化を説明します.
  • 甲状腺機能の正常化は通常,血液動力学的異常を逆転させるため,甲状腺疾患の心臓効果を認識することは極めて重要です.

研究 の 目的:

  • 甲状腺疾患の心血管症状をレビューする.
  • 診断用甲状腺機能検査と,ユータイロイド状態を達成するための治療について議論する.
  • 心不全およびアミオダロン誘発の甲状腺機能障害における甲状腺ホルモン代謝を検査する.

主な方法:

  • 細胞メカニズム,臨床的発見,診断検査,甲状腺疾患に関連する心血管疾患の治療に焦点を当てた文献レビュー.
  • 慢性心不全における甲状腺ホルモン代謝の分析.
  • アミオダロン誘発の甲状腺機能障害に対する管理戦略のレビュー.

主要な成果:

  • 甲状腺機能障害は,心臓の出力,収縮性,血圧,心拍の変化を含む,重要な心血管変化につながります.
  • 適切な甲状腺機能検査は診断に役立ちますし,ユータイロイド状態を回復するための治療は心血管異常を逆転させます.
  • 慢性心不全は甲状腺ホルモンの代謝を変化させ,アミオダロンの使用は,特定の管理を必要とする甲状腺機能テストの異常を引き起こす可能性があります.

結論:

  • 甲状腺疾患の心血管への影響は顕著で,適切な治療で逆戻りします.
  • 甲状腺機能検査による正確な診断と,ユータイロイド状態を達成することは,これらの状態の管理の鍵です.
  • 心不全およびアミオダロン使用における甲状腺機能不全については,特別な考慮が必要である.